BIOTECHNOLOGY VALUE FUND L P - 09 Jun 2025 SCHEDULE 13G Report for Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share (PTGX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share
Symbol
PTGX
Shares outstanding
61.8M shares
Disclosed Ownership
3.21M shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
16 Jun 2025, 17:30:24 UTC
Date of event
09 Jun 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 2.7% 1.68M 0 1.68M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 2.7% 1.68M 0 1.68M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 2.1% 1.28M 0 1.28M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 2.1% 1.28M 0 1.28M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.3% 181K 0 181K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.3% 181K 0 181K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 4.8% 2.96M 0 2.96M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 5.2% 3.21M 0 3.21M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 5.2% 3.21M 0 3.21M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 5.2% 3.21M 0 3.21M /s/ Mark N. Lampert Mark N. Lampert